Tevogen.AI Improves PredicTcell Accuracy for Drug Discovery
WARREN, New Jersey, March 13, 2026 Biotechnology innovator Tevogen Bio Holdings Inc. has announced significant advancements in its Tevogen.AI...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
WARREN, New Jersey, March 13, 2026 Biotechnology innovator Tevogen Bio Holdings Inc. has announced significant advancements in its Tevogen.AI...
March 05, 2026 — South San Francisco, California, USA Global life sciences leader Thermo Fisher Scientific has announced the...
VANCOUVER, CANADA | January 22, 2026 — LIR Life Sciences has announced the completion of the study design for...
